Search research articles
Contact Us
Filters
Showing results (31-40 of 216) with videos related to
Page
of 22
Sort By:
Theranostics
|
January 9, 2026
Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationships
Nicolas M Geis, Yvonne Braunwarth, Philipp T Meyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
18F-CPFPX PET: on the generation of parametric images and the effect of scan duration
Philipp T Meyer, David Elmenhorst, Andreas Matusch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2013
Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia
Lars Frings, Timo S Spehl, Wolfgang A Weber, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2025
Neuroimaging in multiple system atrophy: clinical implications and novel developments
Wolfgang H Jost, Alexander Rau, Joachim Brumberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 24, 2007
Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET
David Elmenhorst, Philipp T Meyer, Andreas Matusch, et al.
Cancers
|
January 11, 2022
Early PSA Change after [<sup>177</sup>Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival
Felix Kind, Thomas F Fassbender, Geoffroy Andrieux, et al.
EJNMMI Research
|
April 11, 2022
Bone marrow impairment during early [<sup>177</sup>Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Felix Kind, Kerstin Michalski, Elham Yousefzadeh-Nowshahr, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2018
Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population
Lars Frings, Sabine Hellwig, Tobias Bormann, et al.
Plos One
|
December 25, 2015
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
Eleni Gourni, Coline Canovas, Victor Goncalves, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2021
Assessing Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brueggemann, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 216) with videos related to
Sort By:
Page
of 22
Theranostics
|
January 9, 2026
Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationships
Nicolas M Geis, Yvonne Braunwarth, Philipp T Meyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
18F-CPFPX PET: on the generation of parametric images and the effect of scan duration
Philipp T Meyer, David Elmenhorst, Andreas Matusch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2013
Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia
Lars Frings, Timo S Spehl, Wolfgang A Weber, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2025
Neuroimaging in multiple system atrophy: clinical implications and novel developments
Wolfgang H Jost, Alexander Rau, Joachim Brumberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 24, 2007
Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET
David Elmenhorst, Philipp T Meyer, Andreas Matusch, et al.
Cancers
|
January 11, 2022
Early PSA Change after [<sup>177</sup>Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival
Felix Kind, Thomas F Fassbender, Geoffroy Andrieux, et al.
EJNMMI Research
|
April 11, 2022
Bone marrow impairment during early [<sup>177</sup>Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Felix Kind, Kerstin Michalski, Elham Yousefzadeh-Nowshahr, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2018
Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population
Lars Frings, Sabine Hellwig, Tobias Bormann, et al.
Plos One
|
December 25, 2015
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
Eleni Gourni, Coline Canovas, Victor Goncalves, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 2021
Assessing Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brueggemann, et al.
Page
of 22